Low-dose anti-thymocyte globulin plus low-dose post-transplant cyclophosphamide-based regimen for prevention of graft-versus-host disease after haploidentical peripheral blood stem cell transplants: a large sample, long-term follow-up retrospective study

IntroductionThe novel low-dose anti-thymocyte (ATG, 5 mg/kg) plus low-dose post-transplant cyclophosphamide (PTCy, 50 mg/kg) (low-dose ATG/PTCy)-based regimen had promising activity for prevention of graft-versus-host disease (GVHD) in haploidentical-peripheral blood stem cell transplantation (haplo...

Descripció completa

Dades bibliogràfiques

Autors principals:	Xingying Li, Jun Yang, Yu Cai, Chongmei Huang, Xiaowei Xu, Huiying Qiu, Jiahua Niu, Kun Zhou, Ying Zhang, Xinxin Xia, Yu Wei, Chang Shen, Yin Tong, Baoxia Dong, Liping Wan, Xianmin Song
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2023-10-01
Col·lecció:	Frontiers in Immunology
Matèries:	graft-versus-host disease haploidentical peripheral blood stem cell transplantation anti-thymocyte globulin cyclophosphamide
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1252879/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!